SM

Sabby Management Portfolio holdings

AUM $12M
1-Year Est. Return 79.04%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
-79.04%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$12M
AUM Growth
-$7.27M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
47
New
Increased
Reduced
Closed

Top Buys

1
+$3.07M
2
+$2.19M
3
+$1.72M
4
TPST icon
Tempest Therapeutics
TPST
+$1.26M
5
ZONE
CleanCore Solutions
ZONE
+$1.21M

Top Sells

1
+$1.08M
2
+$886K
3
+$871K
4
SVRN
OceanPal Inc
SVRN
+$823K
5
BIAF icon
bioAffinity Technologies
BIAF
+$719K

Sector Composition

1 Healthcare 28.39%
2 Consumer Staples 17.47%
3 Consumer Discretionary 15.71%
4 Industrials 13.96%
5 Financials 13.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACXP icon
26
Acurx Pharmaceuticals
ACXP
$9.05M
– –
-8,705
BIAF icon
27
bioAffinity Technologies
BIAF
$13M
– –
-242,757
BJDX icon
28
Bluejay Diagnostics
BJDX
$2.03M
– –
-7,407
SLAI
29
SOLAI Ltd
SLAI
$15.7M
– –
-3,865
CANF
30
Can-Fite BioPharma American Depositary Shares
CANF
$6.86M
– –
-70,303
CETX icon
31
Cemtrex
CETX
$12.6M
– –
-24,987
CORZ icon
32
Core Scientific
CORZ
$5.99B
– –
-1,040
EOSE icon
33
Eos Energy Enterprises
EOSE
$2.4B
– –
0
EVEX icon
34
Eve Holding
EVEX
$972M
– –
-232,458
GEVO icon
35
Gevo
GEVO
$481M
– –
0
GOVX icon
36
GeoVax Labs
GOVX
$2.87M
– –
-26,455
OEF icon
37
iShares S&P 100 ETF
OEF
$19.1B
– –
0
SVRN
38
OceanPal Inc
SVRN
$20.2M
– –
-668,969
RVPH icon
39
Reviva Pharmaceuticals
RVPH
$11.3M
– –
0
SNGX icon
40
Soligenix
SNGX
$11.9M
– –
-81,000
TC
41
TuanChe
TC
$231M
– –
-3,983
UCAR
42
U Power Ltd
UCAR
$2.77M
– –
-240,260
VMAR icon
43
Vision Marine Technologies
VMAR
$2.6M
– –
-4,663
ZVRA icon
44
Zevra Therapeutics
ZVRA
$604M
– –
0
WOK
45
WORK Medical Technology Group
WOK
$1.43M
– –
-272
AIM
46
AIM ImmunoTech
AIM
$4.37M
– –
-28,884
RUBI
47
Rubico Inc
RUBI
$2.85M
– –
-89
1
2